(Q50054341)

English

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

scientific article published on 8 November 2017

Statements

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit